Masimo

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Masimo and other ETFs, options, and stocks.

About MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. 

CEO
Catherine M. Szyman
CEOCatherine M. Szyman
Employees
9,200
Employees9,200
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1989
Founded1989
Employees
9,200
Employees9,200

MASI Key Statistics

Market cap
7.47B
Market cap7.47B
Price-Earnings ratio
-13.10
Price-Earnings ratio-13.10
Dividend yield
Dividend yield
Average volume
600.70K
Average volume600.70K
High today
$140.34
High today$140.34
Low today
$135.20
Low today$135.20
Open price
$138.41
Open price$138.41
Volume
530.29K
Volume530.29K
52 Week high
$194.88
52 Week high$194.88
52 Week low
$125.94
52 Week low$125.94

Stock Snapshot

With a market cap of 7.47B, Masimo(MASI) trades at $138.92. The stock has a price-to-earnings ratio of -13.10.

On 2026-01-10, Masimo(MASI) stock traded between a low of $135.20 and a high of $140.34. Shares are currently priced at $138.92, which is +2.8% above the low and -1.0% below the high.

Masimo(MASI) shares are trading with a volume of 530.29K, against a daily average of 600.7K.

In the last year, Masimo(MASI) shares hit a 52-week high of $194.88 and a 52-week low of $125.94.

In the last year, Masimo(MASI) shares hit a 52-week high of $194.88 and a 52-week low of $125.94.

MASI News

Simply Wall St 2d
Assessing Masimo Valuation As Shares Trade Below Popular Undervalued Fair Value Narrative

With no single headline event driving attention today, Masimo (MASI) is on investors’ radars as a medical technology maker with mixed return figures, as well as...

Assessing Masimo Valuation As Shares Trade Below Popular Undervalued Fair Value Narrative
TipRanks 3d
Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch

Masimo Corp. (MASI) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Masimo Corp. is sponsoring a new clinical study titled...

Benzinga 6d
Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes

From Taiwan Semiconductor Manufacturing Company Ltd securing a crucial U.S. export license to Masimo Corp. facing quality concerns despite a significant patent...

Weekend Round-Up: TSMC's US Export Approval, Masimo's Quality Concerns And Apple's Vision Pro Woes

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

More MASI News

Benzinga 6d
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse

The past week brought a mixed bag of news, with Apple Inc. (NASDAQ:AAPL) at the center of several stories. The tech giant’s rival, Masimo Corp. (NASDAQ:MASI), s...

Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse

People also own

Based on the portfolios of people who own MASI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.